Cargando…

Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool

BACKGROUND: Questionnaires are used in research and clinical practice. For gastrointestinal complaints the Rome II questionnaire is internationally known but not validated. The aim of this study was to validate a printed and a computerized version of Rome II, translated into Swedish. Results from va...

Descripción completa

Detalles Bibliográficos
Autores principales: Molinder, Herdis KM, Kjellström, Lars, Nylin, Henry BO, Agréus, Lars E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806864/
https://www.ncbi.nlm.nih.gov/pubmed/20040091
http://dx.doi.org/10.1186/1477-7525-7-106
_version_ 1782176342306979840
author Molinder, Herdis KM
Kjellström, Lars
Nylin, Henry BO
Agréus, Lars E
author_facet Molinder, Herdis KM
Kjellström, Lars
Nylin, Henry BO
Agréus, Lars E
author_sort Molinder, Herdis KM
collection PubMed
description BACKGROUND: Questionnaires are used in research and clinical practice. For gastrointestinal complaints the Rome II questionnaire is internationally known but not validated. The aim of this study was to validate a printed and a computerized version of Rome II, translated into Swedish. Results from various analyses are reported. METHODS: Volunteers from a population based colonoscopy study were included (n = 1011), together with patients seeking general practice (n = 45) and patients visiting a gastrointestinal specialists' clinic (n = 67). The questionnaire consists of 38 questions concerning gastrointestinal symptoms and complaints. Diagnoses are made after a special code. Our validation included analyses of the translation, feasibility, predictability, reproducibility and reliability. Kappa values and overall agreement were measured. The factor structures were confirmed using a principal component analysis and Cronbach's alpha was used to test the internal consistency. RESULTS AND DISCUSSION: Translation and back translation showed good agreement. The questionnaire was easy to understand and use. The reproducibility test showed kappa values of 0.60 for GERS, 0.52 for FD, and 0.47 for IBS. Kappa values and overall agreement for the predictability when the diagnoses by the questionnaire were compared to the diagnoses by the clinician were 0.26 and 90% for GERS, 0.18 and 85% for FD, and 0.49 and 86% for IBS. Corresponding figures for the agreement between the printed and the digital version were 0.50 and 92% for GERS, 0.64 and 95% for FD, and 0.76 and 95% for IBS. Cronbach's alpha coefficient for GERS was 0.75 with a span per item of 0.71 to 0.76. For FD the figures were 0.68 and 0.54 to 0.70 and for IBS 0.61 and 0.56 to 0.66. The Rome II questionnaire has never been thoroughly validated before even if diagnoses made by the Rome criteria have been compared to diagnoses made in clinical practice. CONCLUSION: The accuracy of the Swedish version of the Rome II is of doubtful value for clinical practice and research. The results for reproducibility and reliability were acceptable but the outcome of the predictability test was poor with IBS as an exception. The agreement between the digital and the paper questionnaire was good.
format Text
id pubmed-2806864
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28068642010-01-15 Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool Molinder, Herdis KM Kjellström, Lars Nylin, Henry BO Agréus, Lars E Health Qual Life Outcomes Research BACKGROUND: Questionnaires are used in research and clinical practice. For gastrointestinal complaints the Rome II questionnaire is internationally known but not validated. The aim of this study was to validate a printed and a computerized version of Rome II, translated into Swedish. Results from various analyses are reported. METHODS: Volunteers from a population based colonoscopy study were included (n = 1011), together with patients seeking general practice (n = 45) and patients visiting a gastrointestinal specialists' clinic (n = 67). The questionnaire consists of 38 questions concerning gastrointestinal symptoms and complaints. Diagnoses are made after a special code. Our validation included analyses of the translation, feasibility, predictability, reproducibility and reliability. Kappa values and overall agreement were measured. The factor structures were confirmed using a principal component analysis and Cronbach's alpha was used to test the internal consistency. RESULTS AND DISCUSSION: Translation and back translation showed good agreement. The questionnaire was easy to understand and use. The reproducibility test showed kappa values of 0.60 for GERS, 0.52 for FD, and 0.47 for IBS. Kappa values and overall agreement for the predictability when the diagnoses by the questionnaire were compared to the diagnoses by the clinician were 0.26 and 90% for GERS, 0.18 and 85% for FD, and 0.49 and 86% for IBS. Corresponding figures for the agreement between the printed and the digital version were 0.50 and 92% for GERS, 0.64 and 95% for FD, and 0.76 and 95% for IBS. Cronbach's alpha coefficient for GERS was 0.75 with a span per item of 0.71 to 0.76. For FD the figures were 0.68 and 0.54 to 0.70 and for IBS 0.61 and 0.56 to 0.66. The Rome II questionnaire has never been thoroughly validated before even if diagnoses made by the Rome criteria have been compared to diagnoses made in clinical practice. CONCLUSION: The accuracy of the Swedish version of the Rome II is of doubtful value for clinical practice and research. The results for reproducibility and reliability were acceptable but the outcome of the predictability test was poor with IBS as an exception. The agreement between the digital and the paper questionnaire was good. BioMed Central 2009-12-29 /pmc/articles/PMC2806864/ /pubmed/20040091 http://dx.doi.org/10.1186/1477-7525-7-106 Text en Copyright ©2009 Molinder et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Molinder, Herdis KM
Kjellström, Lars
Nylin, Henry BO
Agréus, Lars E
Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool
title Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool
title_full Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool
title_fullStr Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool
title_full_unstemmed Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool
title_short Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool
title_sort doubtful outcome of the validation of the rome ii questionnaire: validation of a symptom based diagnostic tool
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806864/
https://www.ncbi.nlm.nih.gov/pubmed/20040091
http://dx.doi.org/10.1186/1477-7525-7-106
work_keys_str_mv AT molinderherdiskm doubtfuloutcomeofthevalidationoftheromeiiquestionnairevalidationofasymptombaseddiagnostictool
AT kjellstromlars doubtfuloutcomeofthevalidationoftheromeiiquestionnairevalidationofasymptombaseddiagnostictool
AT nylinhenrybo doubtfuloutcomeofthevalidationoftheromeiiquestionnairevalidationofasymptombaseddiagnostictool
AT agreuslarse doubtfuloutcomeofthevalidationoftheromeiiquestionnairevalidationofasymptombaseddiagnostictool